The largest database of trusted experimental protocols

Spectramax mz

Manufactured by Molecular Devices

The SpectraMax Mz is a multi-mode microplate reader designed for high-performance absorbance, fluorescence, and luminescence detection. It offers a broad wavelength range and flexible configuration options to support a variety of applications in life science research and drug discovery.

Automatically generated - may contain errors

4 protocols using spectramax mz

1

Blood-Brain Barrier Permeability Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
BBB permeability was assessed using sodium-fluorescein (NaF) (Sigma), a low-molecular mass molecule (376 Da), to detect fluid-phase shifts between the circulation and central nervous system. Briefly, mice received 100 μl of 10% NaF in PBS intraperitoneally and cardiac blood was collected 10 min later. Mice were transcardially perfused with 10 ml of PBS, and spinal cord and brain removed. Each tissue was weighed, homogenized in PBS using a TissueLyser (Qiagen) and centrifuged at 14,000g for 2 min. A volume of 500 μl of clarified supernatant was added to 500 μl of 15% trichloroacetic acid (Sigma) and centrifuged at 10,000g for 10 min. A volume of 125 μl of 5 N NaOH (Sigma-Aldrich) was added to 500 μl of the supernatant and NaF content measured on a SpectraMax Mz (Molecular Devices) microplate reader using standards ranging from 125 to 4,000 μg. NaF in spinal cord or brain was normalized to sera NaF content using the formula: (mg fluorescence brain tissue per mg of protein)/(mg fluorescence sera per μl of blood). Data are expressed as fold increases in NaF in the spinal cord or brain with levels from WT-treated mice set at 1.
+ Open protocol
+ Expand
2

Virus Neutralizing Antibody Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Virus neutralizing Ab was measured as described (39 (link)). Briefly, duplicates of serial 2-fold dilutions of heat inactivated serum from individual mice (n ≥ 5) were incubated with 50 PFU of JHMV in 96-well plates for 90 min at 37°C. Following addition of DBT cells (8 × 104 cells/well) plates were incubated at 37°C for 48 hr. Neutralization titers represent the log10 of the highest average serum dilution that inhibited cytopathic effect. Total virus-specific IgG was measured by ELISA as described (29 (link), 30 (link)). Briefly, plates were coated with 100 μl of a serum free supernatant derived from JMHV infected DBT cells and incubated overnight at 4°C. Plates were washed with PBS containing 0.05% Tween-20 and blocked with 10% FCS in PBS overnight at 4°C. Serum samples were diluted 2-fold in PBS and incubated overnight at 4°C. Following washing, bound Ab was detected using biotinylated goat anti-mouse IgG (Jackson ImmunoResearch Laboratories), streptavidin horseradish peroxidase (BD Bioscience) and 3,3′,5,5′ Tetramethylbenzidine (TMB Reagent Set; BD Bioscience). Optical densities were read at 450 nm on a SpectraMax Mz (Molecular Devices, Sunnydale, CA) microplate reader and titers calculated as reciprocals of the highest dilution that exceeded 2-fold ± standard errors of the means (SEM) over naive controls.
+ Open protocol
+ Expand
3

Virus Neutralization and Total IgG Assays

Check if the same lab product or an alternative is used in the 5 most similar protocols
Virus neutralizing Ab was measured as described (Tschen et al., 2002 (link)). Briefly, duplicates of serial 2-fold dilutions of heat inactivated serum from individual mice (n ⩾ 5) were incubated with 50 PFU of JHMV in 96-well plates for 90 min at 37 °C. Following addition of DBT cells (8 × 104 cells/well) plates were incubated at 37 °C for 48 h. Neutralization titers represent the log10 of the highest average serum dilution that inhibited cytopathic effect. Total virus-specific IgG was measured by ELISA as described (Tschen et al., 2002 (link), Tschen et al., 2006 (link)). Briefly, plates were coated with 100 μl of a serum free supernatant derived from JMHV infected DBT cells and incubated overnight at 4 °C. Plates were washed with PBS containing 0.05% Tween-20 and blocked with 10% FCS in PBS overnight at 4 °C. Serum samples were diluted 2-fold in PBS and incubated overnight at 4 °C. Following washing, bound Ab was detected using biotinylated goat anti-mouse IgG (Jackson ImmunoResearch Laboratories), streptavidin horseradish peroxidase (BD Bioscience) and 3,3′,5,5′ Tetramethylbenzidine (TMB Reagent Set; BD Bioscience). Optical densities were read at 450 nm on a SpectraMax Mz (Molecular Devices, Sunnydale, CA) microplate reader and titers calculated as reciprocals of the highest dilution that exceeded 2-fold ± standard errors of the means (SEM) over naive controls.
+ Open protocol
+ Expand
4

Assessing Blood-Brain Barrier Permeability

Check if the same lab product or an alternative is used in the 5 most similar protocols
To detect fluid-phase shifts between the circulation and CNS, BBB permeability
was assessed using sodium-fluorescein (NaF). Briefly, mice received 100 μL of
10% NaF in PBS (IP) and cardiac blood was collected 10 min later. Mice were
transcardially perfused with 10 mL of PBS and brains were removed. Each tissue
was weighed, homogenized in PBS using a TissueLyser (Qiagen), and centrifuged at
14,000 g for 2 min. A volume of 500 μL of clarified
supernatant was added to 500 μL of 15% trichloroacetic acid (Sigma) and
centrifuged at 10,000 g for 10 min. A volume of 125 μL of 5 N
NaOH (Sigma-Aldrich) was added to 500 μL of the supernatant and NaF content was
measured on a SpectraMax Mz (Molecular Devices) microplate reader using
standards ranging from 125 to 4,000 μg. NaF in the brain was normalized to sera
NaF content using the formula: (μg of NaF in brain tissue per mg of protein)/(μg
of NaF in sera per μL of blood). Data are expressed as fold increases in NaF in
the brain, with levels from PBS-treated mice set at 1. For the positive control,
C57BL/6 mice were infected at 6 to 7 weeks of age by intracranial injection into
the left cerebral hemisphere with 1,000 plague-forming units (PFU) of the
J.2.2v-1 monoclonal Ab-derived glia-tropic JHMV variant in 30 μL sterile PBS
(Fleming et al.,
1986
; Phares et
al., 2014
).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!